Plain-English translation of NCT07091123 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial compares two implanted devices designed to relieve chronic back pain in people who haven't found relief through other treatments. One device, called spinal cord stimulation, works by sending electrical pulses to reduce pain signals. The other, called an intrathecal drug delivery system (or pain pump), delivers pain medication directly into the fluid around your spine. The study lets you try both treatments as temporary tests before deciding which one—if either—to have surgically implanted permanently.
Doctors know both of these devices can help some people with severe back pain, but there's no clear evidence about which treatment works better for individual patients. This study exists to let patients safely test both options and choose based on their own experience, rather than guessing which device might help them most.
You likely qualify if…
You likely don't qualify if…
You will have two separate trial periods—one testing each device—spaced about 2 to 4 weeks apart. In each trial, a temporary device is placed using a needle procedure, and you'll wear it for 8 to 23 hours while going about your day. After both trials are complete, you'll visit the clinic to fill out questionnaires describing which treatment relieved your pain better. If either treatment reduces your pain by at least 50%, you can choose to have that device surgically implanted as a permanent solution. If neither helps enough, the study ends without any implant. The study's formal data collection finishes after these trials and questionnaires; any follow-up care after an implant would be regular clinic visits as normal.
AI-generated summary from trial data · Sep 24, 2026 · Not medical advice
United States